![logo](/logos/DARE.webp)
Daré Bioscience, Inc.
NASDAQ:DARE
3.42 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Daré Bioscience, Inc. |
Symbool | DARE |
Munteenheid | USD |
Prijs | 3.42 |
Beurswaarde | 29,228,551 |
Dividendpercentage | 0% |
52-weken bereik | 3.05 - 7.56 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Ms. Sabrina Martucci Johnson |
Website | https://www.darebioscience.com |
An error occurred while fetching data.
Over Daré Bioscience, Inc.
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription product for the treatment
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)